PolyPid Ltd. operates as a phase 3 biopharma company. Its proprietary PLEX technology pairs with medications, enables precise delivery of drugs at effective release rates, over pre-determined durations ranging from several days to months. The firm's product candidates are designed to address unmet medical needs by delivering active pharmaceutical ingredients, or APIs, locally at predetermined release rates and durations over extended periods ranging from days to several months. The company was founded by Noam Emanuel on February 28, 2008 and is headquartered in Petach Tikva, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
61
Frequently Asked Questions
What is Market Cap of Polypid Ltd?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Polypid Ltd market cap is $35.36M.
What is the 52-week high for Polypid Ltd?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Polypid Ltd 52 week high is $3.93 as of September 16, 2025.
What is the 52-week low for Polypid Ltd?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Polypid Ltd 52 week low is $2.30 as of September 16, 2025.
What is Polypid Ltd stock price today?
Polypid Ltd stock price today is $3.39.
What was Polypid Ltd stock price yesterday?
Polypid Ltd stock price yesterday was $3.47.
What is the PE ratio of Polypid Ltd?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Polypid Ltd’s P/E ratio is -0.91.
What is the Price-to-Book ratio of Polypid Ltd?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Polypid Ltd P/B ratio is 2.6528.
What is the 50-day moving average of Polypid Ltd?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Polypid Ltd 50-day moving average is $3.48.
